Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Houston’s Capital Royalty Evolving in Healthcare Growth Financing 11/19/13 Texas
UW Spinoff Resolve Therapeutics Snags $5.8M for Lupus Drug 11/01/12 Seattle
Innovimmune Pursues Pharma Partners, Shuns VCs 08/07/12 New York
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets 10/12/11 New York
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
The New Normal for Biotech Startups 01/26/11 Seattle
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners 12/15/10 Boston
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan 11/10/10 Seattle
La Jolla Pharmaceutical Revives With $6M Financing 05/26/10 San Diego
La Jolla Pharmaceutical: Going, Going, But Not Quite Gone 02/26/10 San Diego
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Zymo Drug Fails Arthritis Trials 09/10/09 Seattle
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News 07/23/09 Seattle
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug 07/21/09 Seattle
La Jolla Pharmaceutical Gets Delisting Notice 04/09/09 San Diego
Biogen Idec, Extending Life of its Top-Selling Drug, Eyes Longer-Lasting Shot for MS 03/27/09 Boston
Trubion Starts Lupus Trial 03/25/09 Seattle
Biogen Idec, Genentech’s Rituxan Fails in Pivotal Study of Lupus of Kidneys 03/11/09 Boston
Cypress Buys Lupus Test 02/24/09 San Diego
La Jolla Pharmaceutical Looks at Sale or “Winding Down” 02/20/09 San Diego
La Jolla Pharmaceutical Stock Crashes After Drug Fails In Pivotal Clinical Trial 02/12/09 San Diego
Sequenom Buys Small Diagnostic Maker 01/26/09 San Diego
La Jolla Pharma Inks BioMarin Deal 01/07/09 San Diego
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity 12/17/08 Seattle
ZymoGenetics Drug For Hepatitis C Kills Virus with Minimal Side Effects 11/03/08 Seattle
ZymoGenetics Drug Trial Halted Because of Infection Risk 10/27/08 Seattle
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA 09/03/08 Seattle
Page 1 of 2 next page »